Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lim, Chuan Bian ^a   Prêle, Cecilia M ^a,b   Cheah, Hui Min ^a   Cheng, Yuen Yee ^c   Klebe, Sonja ^d   Reid, Glen ^c   Watkins, D Neil ^e   Baltic, Svetlana ^a   Thompson, Philip J ^a   Mutsaers, Steven E ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PATCHED 2; SONIC HEDGEHOG PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENOTYPE; GLI FAMILY ZINC FINGER 1 GENE; GLI FAMILY ZINC FINGER 2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MALE; MALIGNANT MESOTHELIOMA; MISSENSE MUTATION; MOUSE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; PATCHED 1 GENE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTHENED FRIZZLED FAMILY RECEPTOR GENE; SUPPRESSOR OF FUSED HOMOLOG GENE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; FEMALE; HEDGEHOG PROTEINS; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 84879495998     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066685     Document Type: Article

References (77)

1. Robinson BWS, Chahinian AP (2002) Mesothelioma. London: M. Dunitz. xiii, 366 p.
2. Moolgavkar SH, Meza R, Turim J, (2009) Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes Control 20: 935-944.
3. Price B, Ware A, (2004) Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 159: 107-112.
4. Musk AW, de Klerk NH, (2004) Epidemiology of malignant mesothelioma in Australia. Lung Cancer 45Suppl 1: S21-23.
5. Peto J, Decarli A, La Vecchia C, Levi F, Negri E, (1999) The European mesothelioma epidemic. Br J Cancer 79: 666-672.
6. Musk AW, Olsen N, Alfonso H, Reid A, Mina R, et al. (2011) Predicting survival in malignant mesothelioma. Eur Respir J 38: 1420-1424.
7. Lee AY, Raz DJ, He B, Jablons DM, (2007) Update on the molecular biology of malignant mesothelioma. Cancer 109: 1454-1461.
8. Ingham P, McMahon A, (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059-3087.
9. Jiang J, Hui C, (2008) Hedgehog signaling in development and cancer. Dev Cell 15: 801-812.
10. Varjosalo M, Taipale J, (2008) Hedgehog: functions and mechanisms. Genes Dev 22: 2454-2472.
11. Yang L, Xie G, Fan Q, Xie J, (2010) Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 29: 469-481.
12. Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, et al. (1998) Characterization of two patched receptors for the vertebrate hedgehog protein family. Proc Natl Acad Sci U S A 95: 13630-13634.
13. Taipale J, Cooper MK, Maiti T, Beachy PA, (2002) Patched acts catalytically to suppress the activity of Smoothened. Nature 418: 892-897.
14. Humke EW, Dorn KV, Milenkovic L, Scott MP, Rohatgi R, (2010) The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins. Genes Dev 24: 670-682.
15. Kogerman P, Grimm T, Kogerman L, Krause D, Unden AB, et al. (1999) Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nature cell biology 1: 312-319.
16. Murone M, Luoh SM, Stone D, Li W, Gurney A, et al. (2000) Gli regulation by the opposing activities of fused and suppressor of fused. Nature cell biology 2: 310-312.
17. Chuang PT, McMahon AP, (1999) Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397: 617-621.
18. Varjosalo M, Li S, Taipale J, (2006) Divergence of hedgehog signal transduction mechanism between Drosophila and mammals. Dev Cell 10: 177-186.
19. Cheung HO, Zhang X, Ribeiro A, Mo R, Makino S, et al. (2009) The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling. Sci Signal 2: ra29.
20. Katoh Y, Katoh M, (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther 4: 1050-1054.
21. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851.
22. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671.
23. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, et al. (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature genetics 14: 78-81.
24. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, et al. (1997) Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer research 57: 2369-2372.
25. Vorechovsky I, Unden AB, Sandstedt B, Toftgard R, Stahle-Backdahl M, (1997) Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: support for a gatekeeper mechanism in skin tumorigenesis. Cancer research 57: 4677-4681.
26. Maesawa C, Tamura G, Iwaya T, Ogasawara S, Ishida K, et al. (1998) Mutations in the human homologue of the Drosophila patched gene in esophageal squamous cell carcinoma. Genes, chromosomes & cancer 21: 276-279.
27. Ping XL, Ratner D, Zhang H, Wu XL, Zhang MJ, et al. (2001) PTCH mutations in squamous cell carcinoma of the skin. The Journal of investigative dermatology 116: 614-616.
28. McGarvey TW, Maruta Y, Tomaszewski JE, Linnenbach AJ, Malkowicz SB, (1998) PTCH gene mutations in invasive transitional cell carcinoma of the bladder. Oncogene 17: 1167-1172.
29. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L, (2000) PTCH gene mutations in odontogenic keratocysts. Journal of dental research 79: 1418-1422.
30. Sun LS, Li XF, Li TJ, (2008) PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. Journal of dental research 87: 575-579.
31. Song YL, Zhang WF, Peng B, Wang CN, Wang Q, et al. (2006) Germline mutations of the PTCH gene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 27: 175-180.
32. Michimukai E, Kitamura N, Zhang Y, Wang H, Hiraishi Y, et al. (2001) Mutations in the human homologue of the Drosophila segment polarity gene patched in oral squamous cell carcinoma cell lines. In vitro cellular & developmental biology Animal 37: 459-464.
33. Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, et al. (2005) Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. The British journal of dermatology 152: 43-51.
34. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, et al. (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer research 58: 1798-1803.
35. Lam CW, Xie J, To KF, Ng HK, Lee KC, et al. (1999) A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18: 833-836.
36. Couve-Privat S, Bouadjar B, Avril MF, Sarasin A, Daya-Grosjean L, (2002) Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer research 62: 7186-7189.
37. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391: 90-92.
38. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, et al. (1999) Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Human molecular genetics 8: 291-297.
39. Zaphiropoulos PG, Unden AB, Rahnama F, Hollingsworth RE, Toftgard R, (1999) PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas. Cancer research 59: 787-792.
40. Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, et al. (2003) A molecular fingerprint for medulloblastoma. Cancer research 63: 5428-5437.
41. Lee Y, Miller HL, Russell HR, Boyd K, Curran T, et al. (2006) Patched2 modulates tumorigenesis in patched1 heterozygous mice. Cancer research 66: 6964-6971.
42. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nature genetics 31: 306-310.
43. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr, et al. (1997) Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276: 817-821.
44. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, et al. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
45. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
46. Manning LS, Whitaker D, Murch AR, Garlepp MJ, Davis MR, et al. (1991) Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions. Int J Cancer 47: 285-290.
47. Holloway AJ, Diyagama DS, Opeskin K, Creaney J, Robinson BW, et al. (2006) A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin Cancer Res 12: 5129-5135.
48. Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, et al. (2011) Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology 43: 128-132.
49. Jones S, Zhang X, Parsons D, Lin J, Leary R, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
50. Putoux A, Thomas S, Coene KL, Davis EE, Alanay Y,et al. KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes. Nat Genet 43: 601-606.
51. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
52. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
53. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
54. Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, et al. (2012) Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res 18: 4646-4656.
55. Li H, Lui N, Cheng T, Tseng HH, Yue D, et al. (2013) Gli as a novel therapeutic target in malignant pleural mesothelioma. PloS one 8: e57346.
56. Wang XD, Inzunza H, Chang H, Qi Z, Hu B, et al. (2013) Mutations in the hedgehog pathway genes SMO and PTCH1 in human gastric tumors. PloS one 8: e54415.
57. Scales SJ, de Sauvage FJ, (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends in Pharmacological Sciences 30: 303-312.
58. Jiao X, Wood LD, Lindman M, Jones S, Buckhaults P, et al. (2012) Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes, chromosomes & cancer 51: 480-489.
59. Lindstrom E, Shimokawa T, Toftgard R, Zaphiropoulos PG, (2006) PTCH mutations: distribution and analyses. Human mutation 27: 215-219.
60. Lee J, Ekker S, von Kessler D, Porter J, Sun B, et al. (1994) Autoproteolysis in hedgehog protein biogenesis. Science 266: 1528-1537.
61. Lu X, Liu S, Kornberg TB, (2006) The C-terminal tail of the Hedgehog receptor Patched regulates both localization and turnover. Genes Dev 20: 2539-2551.
62. Johnson RL, Milenkovic L, Scott MP, (2000) In vivo functions of the patched protein: requirement of the C terminus for target gene inactivation but not Hedgehog sequestration. Mol Cell 6: 467-478.
63. Marigo V, Davey RA, Zuo Y, Cunningham JM, Tabin CJ, (1996) Biochemical evidence that patched is the Hedgehog receptor. Nature 384: 176-179.
64. Kagawa H, Shino Y, Kobayashi D, Demizu S, Shimada M, et al. (2011) A novel signaling pathway mediated by the nuclear targeting of C-terminal fragments of mammalian Patched 1. PLoS One 6: e18638.
65. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, et al. (2004) PTC gene mutations and expression of SHH, PTC, SMO and GLI-1 in odontogenic keratocysts. International Journal of Oral and Maxillofacial Surgery 33: 584-592.
66. Hafner C, Schmiemann V, Ruetten A, Coras B, Landthaler M, et al. (2007) PTCH mutations are not mainly involved in the pathogenesis of sporadic trichoblastomas. Hum Pathol 38: 1496-1500.
67. Evans T, Boonchai W, Shanley S, Smyth I, Gillies S, et al. (2000) The spectrum of patched mutations in a collection of Australian basal cell carcinomas. Human mutation 16: 43-48.
68. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G, (1997) Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57: 2581-2585.
69. Asplund A, Gustafsson AC, Wikonkal NM, Sela A, Leffell DJ, et al. (2005) PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer. Br J Dermatol 152: 868-873.
70. Chang-Claude J, Dunning A, Schnitzbauer U, Galmbacher P, Tee L, et al. (2003) The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk. Int J Cancer 103: 779-783.
71. Liboutet M, Portela M, Delestaing G, Vilmer C, Dupin N, et al. (2006) MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 126: 1510-1517.
72. Stone DM, Murone M, Luoh S, Ye W, Armanini MP, et al. (1999) Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci 112 (Pt 23): 4437-4448.
73. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nat Genet 31: 306-310.
74. Slade I, Murray A, Hanks S, Kumar A, Walker L, et al. (2011) Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer 10: 337-342.
75. Cancer Genome Atlas N, (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
76. Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, et al. (2010) Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila) 3: 1235-1245.
77. Li D, Duell EJ, Yu K, Risch HA, Olson SH, et al. (2012) Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 33: 1384-1390.